Almost 100% of the mice reconstituted with BCR-ABL (p210)-transduced STAT5a (+/+) BM cells developed classic CML however only a quarter developed the disease with BCR-ABL (p210) transduced STAT5a (−/−) BM cells24. This evidence concerns the gene STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive.